Harvard Bioscience Inc.
HBIO | NASDAQ
$8.90
+$0.10 (+1.14%)
At close: Oct 30, 2026, 4:00 PM ET
$8.90
$0.00 (0.00%)
After-hours:
Oct 30, 2026, 7:30 PM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 8.61M | 4.11M | 4.28M | 4.51M | 7.82M | 8.32M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | 3.5M | n/a | n/a | n/a |
Other Long-Term Assets | 9.86M | 2.83M | 2.97M | 7.78M | 5.38M | 1.09M |
Receivables | 16.04M | 14.87M | 16.1M | 16.71M | 21.83M | 17.77M |
Inventory | 20.81M | 23.25M | 24.72M | 26.44M | 27.59M | 22.26M |
Other Current Assets | 2.76M | 2.9M | 3.94M | 3.47M | 4.34M | 3.36M |
Total Current Assets | 48.23M | 45.12M | 49.04M | 51.12M | 61.58M | 51.7M |
Property-Plant & Equipment | 4.79M | 11.24M | 8.75M | 9.18M | 10.31M | 11.72M |
Goodwill & Intangibles | 17.2M | 67.46M | 73.1M | 77.27M | 85.07M | 91.74M |
Total Long-Term Assets | 31.85M | 81.53M | 88.33M | 94.24M | 100.76M | 104.55M |
Total Assets | 80.07M | 126.64M | 137.37M | 145.36M | 162.34M | 156.25M |
Account Payables | 3.65M | 4.79M | 5.55M | 6.45M | 4.91M | 5.97M |
Deferred Revenue | 4.82M | 3.81M | 4.51M | 3.37M | 4.27M | 3.77M |
Short-Term Debt | 1.53M | 36.96M | 5.86M | 3.81M | 3.24M | 1.72M |
Other Current Liabilities | 10.15M | 8.25M | 9.21M | 7.49M | 10.54M | 7.15M |
Total Current Liabilities | 21.96M | 54.96M | 26.54M | 23.25M | 25.32M | 21.05M |
Long-Term Debt | 35.87M | n/a | 30.7M | 43.01M | 45.1M | 46.29M |
Other Long-Term Liabilities | 1.31M | 1.26M | 1.48M | 1.01M | 486K | 2.85M |
Total Long-Term Liabilities | 44.38M | 8.35M | 37.75M | 49.89M | 53.63M | 58.52M |
Total Liabilities | 66.34M | 63.3M | 64.29M | 73.14M | 78.94M | 79.57M |
Total Debt | 44.28M | 44.5M | 42.77M | 54.24M | 56.96M | 57.6M |
Book Value | 13.73M | 63.34M | 73.07M | 72.22M | 83.4M | 76.68M |
Book Value Per Share | 3.09 | 14.55 | 17.23 | 17.44 | 20.67 | 19.84 |
Common Stock | 447K | 441K | 434K | 454K | 452K | 444K |
Retained Earnings | -214.71M | -158.01M | -145.61M | -142.19M | -132.67M | -132.39M |
Comprehensive Income | -11.67M | -15.67M | -14.19M | -15.05M | -10.03M | -13.07M |
Shareholders Equity | 13.73M | 63.34M | 73.07M | 72.22M | 83.4M | 76.68M |
Total Investments | n/a | n/a | 3.5M | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove HBIO